China’s Low-Cost Drug Mandate Will Benefit Generic Drugmakers

Generic Line
Chinese authorities are gearing up to keep the cost of certain drugs sold in the country down via publication of a “low-cost” drug list expected to expand access to generics.

To View This Article:


Subscribe To Generic Line

Buy This Article Now

Add this article to your cart for $40.00